Abingdon Health Plc (AIM:ABDX)
8.00
-0.75 (-8.57%)
Nov 12, 2026, 3:28 PM GMT
Abingdon Health Revenue
In the fiscal year ending June 30, 2026, Abingdon Health had annual revenue of 10.99M GBP with 30.42% growth. Abingdon Health had revenue of 6.76M in the half year ending June 30, 2026, with 81.37% growth. That makes Abingdon Health the 35,569th largest company in the world by revenue and 697th in the United Kingdom.
Revenue
10.99M
Revenue Growth
+30.42%
P/S Ratio
3.17
Revenue / Employee
83.92K
Employees
131
Market Cap
34.81M
Revenue by Segment
Fiscal year ended Jun 30, 2026 See the full Abingdon Health breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 10.99M | 2.56M | 30.42% |
| Jun 30, 2025 | 8.43M | 2.29M | 37.39% |
| Jun 30, 2024 | 6.14M | 2.09M | 51.67% |
| Jun 30, 2023 | 4.05M | 1.21M | 42.68% |
| Jun 30, 2022 | 2.84M | -8.78M | -75.60% |
| Jun 30, 2021 | 11.62M | 6.38M | 121.93% |
| Jun 30, 2020 | 5.24M | 2.96M | 129.88% |
| Jun 30, 2019 | 2.28M | 886.65K | 63.76% |
| Dec 31, 2016 | 1.39M | 272.59K | 24.38% |
| Dec 31, 2015 | 1.12M | -62.67K | -5.31% |
| Dec 31, 2014 | 1.18M | -688.02K | -36.82% |
| Dec 31, 2013 | 1.87M | 1.09M | 138.72% |
| Dec 31, 2012 | 782.81K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 46.99B |
| GSK plc | 33.54B |
| Haleon | 11.15B |
| Smith & Nephew | 4.77B |
| BATM Advanced Communications | 78.81M |
| Shield Therapeutics | 44.19M |
| hVIVO | 42.09M |
| Renalytix | 2.26M |
Abingdon Health News
- 4 months ago - Abingdon Health plc to Present at the Life Sciences Investor Forum on June 25th - GlobeNewsWire
- 5 months ago - Abingdon Health plc to Present at the Small Cap Growth Virtual Investor Conference June 4th - GlobeNewsWire